

Food makers and restaurants adjust menus and products as GLP-1 drugs drive demand for high-protein foods and smaller portions across the U.S.
You can purchase shares of Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
There are no as such competitors for Amplify Weight Loss Drug & Treatment ETF.
There is no analysis for Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
The stock price for Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $25.9457 last updated October 30, 2026 at 8:00 PM EDT.
There are no upcoming dividends for Amplify Weight Loss Drug & Treatment ETF.
Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Amplify Weight Loss Drug & Treatment ETF.
The Index is comprised of global companies expected to economically benefit from weight loss drug development. The Index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to...